Mental Health6 min read
Tracking PMDD Symptoms: How to Confirm the Diagnosis
Khaled Hamed, PMHNP-C
Written Jun 21, 2026 · Updated Jun 21, 2026
Medically reviewed by: Khaled Hamed, PMHNP-C
Most conditions are diagnosed by what you feel. Premenstrual dysphoric disorder is diagnosed by when you feel it, and that's a problem for memory. Looking back, it's genuinely hard to say whether last month's awful week landed before your period or just blended into a hard stretch. This is why confirming PMDD doesn't rest on recall. It rests on tracking.
The single most useful thing you can do before an evaluation is record your symptoms daily for at least two menstrual cycles. That record is what reveals whether your symptoms truly cluster in the days before your period and lift once it begins, which is the pattern that defines the condition.
Why memory isn't enough
Research has shown that retrospective reports of premenstrual symptoms are unreliable, which is exactly why the diagnostic criteria for PMDD call for prospective daily ratings across at least two symptomatic cycles, not a look back (DSM-5-TR). Tracking forward, day by day, is also what separates PMDD from depression or anxiety that happens to be present all month. If your low mood or irritability never fully clears after your period starts, that points somewhere other than a premenstrual disorder, and it changes the treatment.
What to track each day
Keep it simple and consistent. Each day, note:
- Mood symptoms: irritability or anger, mood swings, sadness or hopelessness, anxiety or tension, and feeling overwhelmed.
- Physical symptoms: bloating, breast tenderness, fatigue, headaches, and changes in sleep or appetite.
- Impact: how much the symptoms interfered with work, relationships, or daily life that day.
- Your cycle: mark the first day of your period each month, so the pattern lines up against it.
A rating scale helps. The standard research tool, the Daily Record of Severity of Problems, has people rate each symptom daily from 1 (not at all) to 6 (extreme), and it's a validated, reliable way to capture both severity and timing (Endicott et al., 2006). A clinician looks for symptom scores in the luteal phase that are meaningfully higher than in the week or so after your period, then ease again.
What the pattern tells you
A clear picture, repeated across two cycles, is powerful. Symptoms that rise in the luteal phase and fall away after menstruation support a diagnosis of premenstrual dysphoric disorder. Symptoms that are present throughout the cycle point instead toward an ongoing mood or anxiety condition, or toward a premenstrual worsening of something already there. Tracking is also what distinguishes PMDD from ordinary premenstrual syndrome, since the difference is in the severity and the impact, not just the timing.
Making it count
Two full cycles is the target, ideally completed before or by your appointment, since it gives a clinician something concrete to work from and speeds an accurate diagnosis. A dedicated app, a period tracker with a notes field, or a simple notebook all work; what matters is doing it daily rather than reconstructing it later. Once the pattern is confirmed, the conversation moves to treatment, which for PMDD often starts with an SSRI.
There's a quieter benefit too. After years of wondering whether it's all in your head, watching the same pattern appear in black and white can be a relief in itself, and it hands you something concrete to act on.
If your premenstrual symptoms ever include thoughts of harming yourself, please don't wait for the next cycle. Call or text 988, the Suicide & Crisis Lifeline, any time.
Book your first evaluation, and bring whatever tracking you have; it gives us a real head start.
If any of this sounds familiar, you don't have to sort it out alone - book your first evaluation and we'll take it from there.
By the numbers
Each figure links to its primary source.
- ≥2 cycles of prospective daily tracking required
- The diagnostic criteria for PMDD require confirmation by prospective daily symptom ratings across at least two symptomatic menstrual cycles, because retrospective recall of premenstrual symptoms is unreliable.Source: DSM-5-TR; Endicott et al., 2006
Frequently asked questions
How is PMDD diagnosed?
By tracking symptoms daily for at least two menstrual cycles to confirm they cluster before the period and lift after it starts. The diagnosis rests on this prospective pattern, not on memory.
Why do I need to track for two cycles?
Because PMDD is defined by its timing, and one cycle isn't enough to confirm a reliable pattern. The diagnostic criteria specifically call for prospective daily ratings across at least two symptomatic cycles.
What should I record each day?
Mood symptoms (irritability, mood swings, sadness, anxiety, feeling overwhelmed), physical symptoms (bloating, breast tenderness, fatigue), how much they interfered with your day, and the first day of each period.
What is the DRSP?
The Daily Record of Severity of Problems, a validated daily questionnaire that rates each symptom from 1 to 6. It's the standard research tool for capturing the severity and timing of premenstrual symptoms.
Can an app be used to track PMDD?
Yes. A dedicated app, a period tracker with notes, or a simple notebook all work. What matters is recording daily rather than trying to remember later.
What if my symptoms don't clear after my period?
Then it likely isn't PMDD. Symptoms present throughout the cycle point toward an ongoing mood or anxiety condition, or a premenstrual worsening of something already there, which is treated differently.
References
- American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Publishing.
- Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Archives of Women's Mental Health. 2006;9(1):41-49.
- Hofmeister S, Bodke S. Premenstrual Syndrome and Premenstrual Dysphoric Disorder. American Family Physician. 2016;94(3):236-240.
- Jespersen C, Lauritsen MP, Frokjaer VG, et al. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. Cochrane Database of Systematic Reviews. 2024, Issue 8. Art. No.: CD001396.